<DOC>
	<DOCNO>NCT01684020</DOCNO>
	<brief_summary>Rhinoplasty ( nasal reconstruction i.e . `` nose job '' ) surgical procedure perform nose correct medical problem change appearance nose . During heal process , swell and/or bruise likely occur . A drug call ARTISS Fibrin Sealant may may lessen effect . This study look see effect ARTISS adhere tissue improve wound heal external rhinoplasty . The purpose study evaluate safety effectiveness rhinoplasty use ARTISS compare rhinoplasty without use ARTISS patient undergo rhinoplasty perform external approach .</brief_summary>
	<brief_title>A Study Evaluating Efficacy Safety ARTISS Human Fibrin Sealant Used External Rhinoplasty</brief_title>
	<detailed_description />
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>1 . Males females 18 65 year age . 2 . Subjects request primary rhinoplasty require external approach . 3 . Subjects willing undergo treatment fibrin sealant . 4 . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . 5 . Willingness ability comply PI 's standard preoperative postoperative rhinoplasty instruction . 6 . Subjects childbearing potential must negative urine pregnancy test result Visit 1 willing able use acceptable method birth control ( e.g. , barrier method use spermicidal agent , hormonal method , IUD , surgical sterilization , abstinence ) study . Women consider childbearing potential one follow document medical history : postmenopausal least 12 month prior study drug administration without uterus and/or ovary bilateral tubal ligation least 6 month prior study drug administration . absence physical condition accord PI 's discretion 7 . Willingness ability provide write photo consent adherence photography procedure ( i.e. , removal jewelry makeup ) . 8 . Willingness ability provide write informed consent prior performance study related procedure . 1 . Subjects pregnant , nursing , plan become pregnant , and/or use reliable form birth control . 2 . Subjects plan concurrent facial surgery operation ( eg forehead plasty , blepharoplasty , rhinoplasty , buccal fat removal , filler injection include fat injection , lip augmentation , skin resurface procedure etc. ) . 3 . Subjects previous history rhinoplasty . 4 . Subjects current history smoking . 5 . Subjects previous history bleed coagulation disorder . 6 . Subject previous history vascular disorder , cardiovascular disease , and/or uncontrolled hypertension . 7 . Subjects previous history diabetes mellitus glycosylated hemoglobin ( HbA1c ) &gt; 7 . 8 . Subjects undergo active treatment malignancy . 9 . Subjects previous history connective tissue disorder . 10 . Subjects active chronic skin disorder . 11 . Subjects previous history Bell 's palsy . 12 . Subjects previous history pathologically pharmacologically induce immune deficiency . 13 . Subjects receive chronic treatment immunosuppressive drug , systemic corticosteroid , chronic treatment within 30 day prior surgery . 14 . Subjects know sensitivity component FS VH S/D 4 sapr . 15 . Subjects previous history heal complication follow previous surgery ( eg , hypertrophic scarring ) . 16 . Subjects significant systemic illness illness localize area treatment . 17 . Subjects previous history nasal implant . 18 . Subjects previous current history nasal infection . 19 . Subjects history blood thinner ( aspirin , ibuprofen , naprosyn , herbal supplement , Vitamin E ) within two week prior surgery . 20 . Subjects smoke within two week prior surgery . 21 . Subjects alcohol illicit drug one week prior surgery . 22 . Subjects eaten drank anything midnight night prior surgery . 23 . Subjects current history chronic drug alcohol abuse . 24 . Concurrent therapy , investigator 's opinion , would interfere evaluation safety efficacy study medication . 25 . Subjects anticipate need surgery , study procedure , overnight hospitalization study . 26 . Subjects , Investigator 's opinion , history poor cooperation , non compliance medical treatment unreliability . 27 . Subject participate another clinical study involve investigational product/device within 30 day prior enrollment schedule participate another clinical study involve investigational product/device course study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>rhinoplasty</keyword>
	<keyword>external rhinoplasty</keyword>
	<keyword>open rhinoplasty</keyword>
	<keyword>nose job</keyword>
</DOC>